PDB Short entry for 2F5M
HEADER    HYDROLASE                               26-NOV-05   2F5M              
TITLE     CROSS-LINKED BARNASE SOAKED IN BROMO-ETHANOL                          
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: RIBONUCLEASE;                                              
COMPND   3 CHAIN: A, B, C;                                                      
COMPND   4 SYNONYM: BARNASE, RNASE BA;                                          
COMPND   5 EC: 3.1.27.-;                                                        
COMPND   6 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: BACILLUS AMYLOLIQUEFACIENS;                     
SOURCE   3 ORGANISM_TAXID: 1390;                                                
SOURCE   4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   5 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   7 EXPRESSION_SYSTEM_PLASMID: PMJ1002                                   
KEYWDS    DENATURATION, LYSOZYME, BARNASE, CROSS-LINKED CRYSTALS,               
KEYWDS   2 GLUTARALDEHYDE, UREA, THIOUREA, BROMOETHANOL, HYDROLASE              
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    T.PRANGE,M.SALEM                                                      
REVDAT   4   23-AUG-23 2F5M    1       REMARK                                   
REVDAT   3   24-FEB-09 2F5M    1       VERSN                                    
REVDAT   2   06-JUN-06 2F5M    1       JRNL                                     
REVDAT   1   25-APR-06 2F5M    0                                                
JRNL        AUTH   M.SALEM,Y.MAUGUEN,T.PRANGE                                   
JRNL        TITL   ON THE EDGE OF THE DENATURATION PROCESS: APPLICATION OF      
JRNL        TITL 2 X-RAY DIFFRACTION TO BARNASE AND LYSOZYME CROSS-LINKED       
JRNL        TITL 3 CRYSTALS WITH DENATURANTS IN MOLAR CONCENTRATIONS.           
JRNL        REF    BIOCHIM.BIOPHYS.ACTA          V.1764   903 2006              
JRNL        REFN                   ISSN 0006-3002                               
JRNL        PMID   16600702                                                     
JRNL        DOI    10.1016/J.BBAPAP.2006.02.009                                 
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.95 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 9.50                           
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 96.0                           
REMARK   3   CROSS-VALIDATION METHOD           : NULL                           
REMARK   3   FREE R VALUE TEST SET SELECTION   : NULL                           
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.178                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : NULL                   
REMARK   3   FREE R VALUE                  (NO CUTOFF) : NULL                   
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL                   
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : NULL                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 22360                  
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : 0.173                  
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : NULL                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 20696                  
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 2592                                          
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 8                                             
REMARK   3   SOLVENT ATOMS      : 205                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : 2796.0                  
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : 2508.0                  
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : 0                       
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 11187                   
REMARK   3   NUMBER OF RESTRAINTS                     : 10765                   
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.007                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.024                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL                    
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.025                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.036                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.044                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.039                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : NULL                    
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.070                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : NULL                    
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: NULL                                                  
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER                      
REMARK   3   SPECIAL CASE: NULL                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2F5M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-FEB-06.                  
REMARK 100 THE DEPOSITION ID IS D_1000035479.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 26-MAR-02                          
REMARK 200  TEMPERATURE           (KELVIN) : 277                                
REMARK 200  PH                             : 8                                  
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : LURE                               
REMARK 200  BEAMLINE                       : DW32                               
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.964                              
REMARK 200  MONOCHROMATOR                  : CURVATED SI(111)                   
REMARK 200  OPTICS                         : CURVATED MULTILAYER MIRROR         
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE                        
REMARK 200  DETECTOR MANUFACTURER          : MARRESEARCH                        
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 20696                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.949                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 9.500                              
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 4.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 95.3                               
REMARK 200  DATA REDUNDANCY                : NULL                               
REMARK 200  R MERGE                    (I) : NULL                               
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 20.1000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.10                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 81.5                               
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 9.700                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS            
REMARK 200 SOFTWARE USED: SHELX                                                 
REMARK 200 STARTING MODEL: 2F4Y                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 45.57                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: FROM AMMONIUM SULFATE, PROTEIN =20       
REMARK 280  MG/ML, PH 8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 300K        
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32                             
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -Y,X-Y,Z+2/3                                            
REMARK 290       3555   -X+Y,-X,Z+1/3                                           
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       54.36667            
REMARK 290   SMTRY1   3 -0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   3 -0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000       27.18333            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1, 2, 3                                                 
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 2                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 3                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ASN A  39   CB  -  CG  -  OD1 ANGL. DEV. =  12.2 DEGREES          
REMARK 500    TRP B  33   CA  -  C   -  N   ANGL. DEV. =  13.8 DEGREES          
REMARK 500    TRP B  33   O   -  C   -  N   ANGL. DEV. = -10.2 DEGREES          
REMARK 500    VAL B  34   C   -  N   -  CA  ANGL. DEV. =  23.0 DEGREES          
REMARK 500    ARG B  67   CD  -  NE  -  CZ  ANGL. DEV. =  22.8 DEGREES          
REMARK 500    ARG B  67   NE  -  CZ  -  NH1 ANGL. DEV. =   3.2 DEGREES          
REMARK 500    VAL C  34   C   -  N   -  CA  ANGL. DEV. =  29.4 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASN A   3       20.47   -147.60                                   
REMARK 500    TRP A  92       32.62     72.49                                   
REMARK 500    ASN B   3       27.91   -151.03                                   
REMARK 500    ILE C   2      141.44    173.86                                   
REMARK 500    ASN C   3       24.05   -145.15                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BRJ B 150                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BRJ B 151                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 2F4Y   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 2F56   RELATED DB: PDB                                   
DBREF  2F5M A    1   108  UNP    P00648   RNBR_BACAM      50    157             
DBREF  2F5M B    1   108  UNP    P00648   RNBR_BACAM      50    157             
DBREF  2F5M C    1   108  UNP    P00648   RNBR_BACAM      50    157             
SEQRES   1 A  108  VAL ILE ASN THR PHE ASP GLY VAL ALA ASP TYR LEU GLN          
SEQRES   2 A  108  THR TYR HIS LYS LEU PRO ASP ASN TYR ILE THR LYS SER          
SEQRES   3 A  108  GLU ALA GLN ALA LEU GLY TRP VAL ALA SER LYS GLY ASN          
SEQRES   4 A  108  LEU ALA ASP VAL ALA PRO GLY LYS SER ILE GLY GLY ASP          
SEQRES   5 A  108  ILE PHE SER ASN ARG GLU GLY LYS LEU PRO GLY LYS SER          
SEQRES   6 A  108  GLY ARG THR TRP ARG GLU ALA ASP ILE ASN TYR THR SER          
SEQRES   7 A  108  GLY PHE ARG ASN SER ASP ARG ILE LEU TYR SER SER ASP          
SEQRES   8 A  108  TRP LEU ILE TYR LYS THR THR ASP HIS TYR GLN THR PHE          
SEQRES   9 A  108  THR LYS ILE ARG                                              
SEQRES   1 B  108  VAL ILE ASN THR PHE ASP GLY VAL ALA ASP TYR LEU GLN          
SEQRES   2 B  108  THR TYR HIS LYS LEU PRO ASP ASN TYR ILE THR LYS SER          
SEQRES   3 B  108  GLU ALA GLN ALA LEU GLY TRP VAL ALA SER LYS GLY ASN          
SEQRES   4 B  108  LEU ALA ASP VAL ALA PRO GLY LYS SER ILE GLY GLY ASP          
SEQRES   5 B  108  ILE PHE SER ASN ARG GLU GLY LYS LEU PRO GLY LYS SER          
SEQRES   6 B  108  GLY ARG THR TRP ARG GLU ALA ASP ILE ASN TYR THR SER          
SEQRES   7 B  108  GLY PHE ARG ASN SER ASP ARG ILE LEU TYR SER SER ASP          
SEQRES   8 B  108  TRP LEU ILE TYR LYS THR THR ASP HIS TYR GLN THR PHE          
SEQRES   9 B  108  THR LYS ILE ARG                                              
SEQRES   1 C  108  VAL ILE ASN THR PHE ASP GLY VAL ALA ASP TYR LEU GLN          
SEQRES   2 C  108  THR TYR HIS LYS LEU PRO ASP ASN TYR ILE THR LYS SER          
SEQRES   3 C  108  GLU ALA GLN ALA LEU GLY TRP VAL ALA SER LYS GLY ASN          
SEQRES   4 C  108  LEU ALA ASP VAL ALA PRO GLY LYS SER ILE GLY GLY ASP          
SEQRES   5 C  108  ILE PHE SER ASN ARG GLU GLY LYS LEU PRO GLY LYS SER          
SEQRES   6 C  108  GLY ARG THR TRP ARG GLU ALA ASP ILE ASN TYR THR SER          
SEQRES   7 C  108  GLY PHE ARG ASN SER ASP ARG ILE LEU TYR SER SER ASP          
SEQRES   8 C  108  TRP LEU ILE TYR LYS THR THR ASP HIS TYR GLN THR PHE          
SEQRES   9 C  108  THR LYS ILE ARG                                              
HET    BRJ  B 150       4                                                       
HET    BRJ  B 151       4                                                       
HETNAM     BRJ 2-BROMOETHANOL                                                   
FORMUL   4  BRJ    2(C2 H5 BR O)                                                
FORMUL   6  HOH   *205(H2 O)                                                    
HELIX    1   1 THR A    4  HIS A   16  1                                  13    
HELIX    2   2 THR A   24  LEU A   31  1                                   8    
HELIX    3   3 VAL A   34  GLY A   38  5                                   5    
HELIX    4   4 ASN A   39  ALA A   44  1                                   6    
HELIX    5   5 THR B    4  HIS B   16  1                                  13    
HELIX    6   6 THR B   24  LEU B   31  1                                   8    
HELIX    7   7 VAL B   34  GLY B   38  5                                   5    
HELIX    8   8 ASN B   39  ALA B   44  1                                   6    
HELIX    9   9 THR C    4  HIS C   16  1                                  13    
HELIX   10  10 THR C   24  LEU C   31  1                                   8    
HELIX   11  11 VAL C   34  GLY C   38  5                                   5    
HELIX   12  12 ASN C   39  ALA C   44  1                                   6    
SHEET    1   A 6 TYR A  22  ILE A  23  0                                        
SHEET    2   A 6 SER A  48  PHE A  54  1  O  SER A  48   N  ILE A  23           
SHEET    3   A 6 TRP A  69  ASP A  73 -1  O  GLU A  71   N  GLY A  51           
SHEET    4   A 6 ARG A  85  SER A  89 -1  O  TYR A  88   N  ARG A  70           
SHEET    5   A 6 ILE A  94  THR A  97 -1  O  TYR A  95   N  LEU A  87           
SHEET    6   A 6 THR A 105  ARG A 108 -1  O  ILE A 107   N  ILE A  94           
SHEET    1   B 6 TYR B  22  ILE B  23  0                                        
SHEET    2   B 6 SER B  48  PHE B  54  1  O  SER B  48   N  ILE B  23           
SHEET    3   B 6 TRP B  69  ASP B  73 -1  O  ASP B  73   N  ILE B  49           
SHEET    4   B 6 ARG B  85  SER B  89 -1  O  TYR B  88   N  ARG B  70           
SHEET    5   B 6 ILE B  94  THR B  97 -1  O  TYR B  95   N  LEU B  87           
SHEET    6   B 6 THR B 105  LYS B 106 -1  O  THR B 105   N  LYS B  96           
SHEET    1   C 6 TYR C  22  ILE C  23  0                                        
SHEET    2   C 6 SER C  48  PHE C  54  1  O  SER C  48   N  ILE C  23           
SHEET    3   C 6 TRP C  69  ASP C  73 -1  O  ASP C  73   N  ILE C  49           
SHEET    4   C 6 ARG C  85  SER C  89 -1  O  ILE C  86   N  ALA C  72           
SHEET    5   C 6 ILE C  94  THR C  97 -1  O  TYR C  95   N  LEU C  87           
SHEET    6   C 6 THR C 105  ARG C 108 -1  O  ILE C 107   N  ILE C  94           
SITE     1 AC1  5 PHE A  80  LYS A 106  LYS B  37  ASN B  39                    
SITE     2 AC1  5 ASP B  42                                                     
SITE     1 AC2  6 PHE B  80  LYS B 106  ARG B 108  LEU C  31                    
SITE     2 AC2  6 VAL C  43  ALA C  44                                          
CRYST1   59.280   59.280   81.550  90.00  90.00 120.00 P 32          9          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.016869  0.009739  0.000000        0.00000                         
SCALE2      0.000000  0.019479  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.012262        0.00000